Here's the live share price of Rubicon Research along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Rubicon Research has gained 0.00% CAGR. Over the past year, the corresponding return has been 0.00%.
Rubicon Research’s current P/E of nullx helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries | 0.12 | 3.07 | -2.38 | -1.91 | -12.52 | 19.22 | 27.81 |
Divi's Laboratories | 7.69 | 8.35 | -3.31 | 14.69 | 7.86 | 22.64 | 15.44 |
Cipla | 3.78 | 0.73 | 6.51 | 4.89 | 0.45 | 12.31 | 14.95 |
Torrent Pharmaceuticals | -0.59 | -0.16 | 1.91 | 9.52 | 0.42 | 30.69 | 20.79 |
Dr. Reddy's Laboratories | -0.47 | -5.39 | -1.51 | 6.93 | -7.61 | 12.68 | 4.05 |
Mankind Pharma | -1.08 | -4.53 | -6.51 | -2.76 | -9.56 | 19.87 | 11.49 |
Zydus Lifesciences | -1.03 | -4.76 | 1.77 | 19.91 | -3.32 | 33.03 | 18.02 |
Lupin | -0.29 | -4.86 | 1.14 | 0.82 | -11 | 41.38 | 13.42 |
Alkem Laboratories | 1.24 | 0.67 | 10.88 | 11.85 | -9.05 | 21.06 | 15.91 |
Aurobindo Pharma | -1.24 | 1.2 | -4.15 | -2.45 | -25.47 | 28.57 | 6.51 |
Abbott India | 0.74 | -3.44 | -12.52 | -2.66 | 3.34 | 18.26 | 13.29 |
Glenmark Pharmaceuticals | -3.74 | -10.29 | -15.42 | 37.32 | 4.62 | 67.8 | 30.58 |
Biocon | 1.84 | -0.24 | -8.95 | 9.18 | 3.77 | 10.86 | -4.31 |
Laurus Labs | 0.8 | -2.32 | 6.36 | 39.5 | 82.09 | 19.48 | 21.8 |
GlaxoSmithKline Pharmaceuticals | -0.89 | -0.16 | -13.59 | -6.64 | 2.04 | 25.8 | 12.5 |
Anthem Biosciences | 0.13 | -6.86 | 5.94 | 5.94 | 5.94 | 1.94 | 1.16 |
Cohance Lifesciences | 1.84 | -9.27 | -15.48 | -25 | -27.19 | 31.64 | 20.66 |
Ipca Laboratories | -3.58 | -1.46 | -11.72 | -8.36 | -22.03 | 13.05 | 4.04 |
Gland Pharma | -2.16 | -5.37 | -2.94 | 32.53 | 14.86 | -3.89 | 0.99 |
Over the last one year, Sun Pharmaceutical Industries has declined 12.52% compared to peers like Divi's Laboratories (7.86%), Cipla (0.45%), Torrent Pharmaceuticals (0.42%). From a 5 year perspective, Sun Pharmaceutical Industries has outperformed peers relative to Divi's Laboratories (15.44%) and Cipla (14.95%).
Rubicon Research Ltd. is a Public Limited Listed company incorporated on 06/05/1999 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U73100MH1999PLC119744 and registration number is 119744. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1073.84 Cr. and Equity Capital is Rs. 15.41 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Rubicon Research is ₹611.60 as on Oct 16, 2025.
The Rubicon Research is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Rubicon Research is ₹0.00 Cr as on Oct 16, 2025.
Today’s highest and lowest price of Rubicon Research are ₹636.15 and ₹590.00.
The 52-week high/low is the highest and lowest price at which Rubicon Research stock has traded in the past 52-week or nearly a year. The 52-week high of Rubicon Research is ₹0.00 and 52-week low of Rubicon Research is ₹0.00 as on Oct 16, 2025.
The Rubicon Research has shown returns of 0.0% over the past day, 0.0% for the past month, 0.0% over 3 months, 0.0% over 1 year, 0.0% across 3 years, and 0.0% over 5 years.
P/E ratio of and PB ratio of Rubicon Research are and on Oct 16, 2025. While the company gives a dividend yield of per annum.